| MERCK KGAA O.N. | 115.90 / +0.17% |
| Date/Time | 01/21 / 08:10 |
| Chg. / Chg.(%) | 0.20 / +0.17% |
| Bid | 116.60 / 117 |
| Ask | 116.65 / 200 |
| Open | 115.90 |
| Previous Close | 115.70 |
| High | 115.90 |
| Low | 115.90 |
| Volume [EUR] | 0.00 |
| Volume [Units] | 0 |
| Price fixings | 1 |
| ISIN | DE0006599905 |
| Security | MRK |
| Exchange | Hannover |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Xetra | 116.65 |  |
108,548 |
| Cboe Europe .. | 116.65 | |
31,512 |
| Cboe Europe .. | 116.60 | |
31,449 |
| Turquoise | 116.65 | |
26,607 |
| London Inter.. | 116.63 | |
8,505 |
| TradeGate | 116.800 | |
1,736 |
| Stuttgart | 116.700 | |
775 |
| Frankfurt | 115.9000 | |
200 |
| München | 116.65 | |
200 |
| Vienna Globa.. | 115.70 | |
0 |
| Hamburg | 115.90 | |
0 |
| Düsseldorf | 115.60 | |
0 |
| Hannover | 115.90 | |
0 |
| Berlin | 116.60 |  |
0 |
| Lang & Schwa.. | 116.600 | |
|
| gettex | 116.800 | |
|
| Borsa Italia.. | 116.00 | 85 | |
| SIX Swiss Ex.. | 102.20 | ||
| SIX Swiss Ex.. | 97.00 | ||
| Nasdaq Other.. | 126.9000 | |
506 |
| EUREX | Options | ||
News
- FDA approves Astra Zeneca, Merck & Co. drug
12/30/2019 / 10:13 - TeleTrader - Merck to acquire ArQule for $2.7B
12/09/2019 / 23:36 - TeleTrader - Vaccinex Reports Third Quarter 2019 Financial Results and Provides Corporate Update
11/12/2019 / 14:00 - GlobeNewswire - Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
11/09/2019 / 14:02 - GlobeNewswire - Merck says Q3 sales jump 12% YoY to $12.4B
10/29/2019 / 11:49 - TeleTrader
Real-time